“Starpharma has many irons in the fire. One of them is Dep Radiotherapeutics” ~ @antibotter
I think this ‘many irons in the fire’ analogy is well past its use by date. Three and a half years since your post and DEP Radiotherapeutics is still pre-clinical.
”Telix could be an off-shoot of Starpharma. It's market cap (TLX) is currently $331 million” ~@antibotter
Since you started this thread comparing both companies, Telix’s share price has appreciated from around $1.78 to $11.38 (market cap $3.6B). Whereas Starpharma has withered on the vine from $1.24 to 45 cents.
In hindsight, backing Dr Chris Behrenbruch over Jackie Fairley would have been a better financial move for many.
SPL Price at posting:
45.5¢ Sentiment: Sell Disclosure: Not Held
